Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Buy” from Analysts

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has received a consensus recommendation of “Buy” from the ten brokerages that are presently covering the stock, Marketbeat reports. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages […]

Leave a Reply

Your email address will not be published.

Previous post Aeva Technologies, Inc. (NYSE:AEVA) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Next post Morgan Stanley Cuts Truist Financial (NYSE:TFC) Price Target to $38.00